Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine in adults 70 years of age and older previously vaccinated with 23-valent pneumococcal polysaccharide vaccine
Under a Creative Commons license
open access
Abbreviations
ACIP
United States Advisory Committee on Immunization Practices
AE
adverse event
CI
confidence interval
CRM197
cross-reactive material 197
GMR
geometric mean ratio
GMT
geometric mean titer
ITP
idiopathic thrombocytopenic purpura
OPA
opsonophagocytic activity
PCV
pneumococcal polysaccharide conjugate vaccine
PCV13
13-valent pneumococcal conjugate vaccine
PPSV23
23-valent polysaccharide vaccine
RCDC
reverse cumulative distribution curve
SAE
serious adverse event
Keywords
Adults
Pneumococcal conjugate vaccine
PCV13
Cited by (0)
Copyright © 2013 The Authors. Published by Elsevier Ltd.